These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2075527

  • 1. [Willebrand's factor, functional activity of blood platelets and antiaggregation activity of the vascular wall in ischemic heart disease].
    Baluda MV, Baluda VP, Novikova IV, Deianov II, Timofeeva AV, Fomina VM, Filonov VK, Emtseva VP.
    Sov Med; 1990; (11):7-9. PubMed ID: 2075527
    [Abstract] [Full Text] [Related]

  • 2. [Plasma level of von Willebrand factor in patients with ischemic heart disease].
    Orlov VN, Vasil'eva EIu, Bespal'ko IA.
    Ter Arkh; 1986; 58(3):57-60. PubMed ID: 3487128
    [Abstract] [Full Text] [Related]

  • 3. Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood.
    Badimon L, Badimon JJ, Rand J, Turitto VT, Fuster V.
    J Lab Clin Med; 1987 Nov; 110(5):634-47. PubMed ID: 3312444
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [von Willebrand's disease and coronary atherosclerosis. Apropos of 3 cases].
    Dulhoste MN, Bonnet J, Vergnes C, Choussat A, Bricaud H.
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1875-8. PubMed ID: 2514640
    [Abstract] [Full Text] [Related]

  • 6. [Elevated levels of plasma von Willebrand factor: a new risk factor for atherosclerosis?].
    Belicová M, Kubisz P, Kicko V, Dvorský J, Funiak S, Kvĕtenský J, Ivanková J.
    Vnitr Lek; 1994 Oct; 40(10):660-2. PubMed ID: 7810085
    [Abstract] [Full Text] [Related]

  • 7. [Von Willebrand factor and the antiaggregation activity of the vascular wall in diabetics].
    Sokolov EI, Baluda MV, Baluda VP, Balabolkin MI, Novikova IV, Deianov II, Timofeeva AV.
    Ter Arkh; 1991 Oct; 63(4):104-5. PubMed ID: 1648796
    [No Abstract] [Full Text] [Related]

  • 8. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ, Pietu G, Rabinowitz R, Girma JP, Rogers J, Meyer D.
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [Abstract] [Full Text] [Related]

  • 9. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR, Williams SB, McKeown LP, Rick ME, Maisonneuve P, Jenneau C, Sultan Y.
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [Abstract] [Full Text] [Related]

  • 10. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ, Rogers J, Brand H.
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [Abstract] [Full Text] [Related]

  • 11. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P, Zwaginga JJ, de Boer HC, Federici AB, Rodeghiero F, Castaman G, Mariani G, Mannucci PM, de Groot PG, Sixma JJ.
    Thromb Haemost; 1990 Oct 22; 64(2):227-31. PubMed ID: 2125373
    [Abstract] [Full Text] [Related]

  • 12. [The prostacyclin-thromboxane system and thrombocytic-vascular hemostasis in patients with ischemic heart disease in the preoperative period].
    Abbakumov VV, Vinnitskiĭ LI, Kattakhanova RIu, Studennikova LN, Egorova IA, Smirnova LA.
    Anesteziol Reanimatol; 1992 Oct 22; (1):42-4. PubMed ID: 1524251
    [Abstract] [Full Text] [Related]

  • 13. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P, Drouin J, Morel-Kopp MC, Hanss M, Kehrel B, Serre CM, Kaplan C, Delmas PD.
    Cancer Res; 1993 Oct 01; 53(19):4695-700. PubMed ID: 7691402
    [Abstract] [Full Text] [Related]

  • 14. [The diagnostic characteristics of von Willebrand's disease].
    Golovina OG, Papaian LP, Beliazo OE, Khrolova PV, Lavrichenko IA, Andreeva TA, Khanina TM.
    Ter Arkh; 1996 Oct 01; 68(4):58-61. PubMed ID: 9324795
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Role of prostacyclin in the antiaggregation activity of the vascular wall].
    Gabrielian ES, Akopov SE, Balaian BG.
    Biull Eksp Biol Med; 1984 Oct 01; 98(10):403-5. PubMed ID: 6388657
    [Abstract] [Full Text] [Related]

  • 18. [A micromethod of determining the Willebrand factor in blood].
    Livshits AM.
    Lab Delo; 1991 Oct 01; (5):24-6. PubMed ID: 1715935
    [Abstract] [Full Text] [Related]

  • 19. [Willebrand's disease and multimeric analysis of the Willebrand factor].
    Hauert J, Tran-Thang C, Bachmann F.
    Schweiz Med Wochenschr; 1985 Dec 07; 115(49):1773-5. PubMed ID: 3879003
    [Abstract] [Full Text] [Related]

  • 20. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM.
    Wien Klin Wochenschr; 1982 Oct 15; 94(19):509-14. PubMed ID: 6818773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.